Aurélie Lacroix, PhD
Aurélie’s research aims at using nucleic acids as a material for self-assembly of nanoparticles with therapeutic properties. She is currently a postdoctoral Marie Skłodowska-Curie fellow at Sixfold Bioscience. The start-up, based in London (UK), develops RNA-based nanostructures for cancer therapies and delivery of gene therapeutics. There, Aurélie is studying how RNA 3D nanostructures interact with serum proteins, to further improve their clinical outcomes.